🇺🇸 FDA
Patent

US 10370449

Methods for treating skin infection by administering an IL-4R antagonist

granted A61KA61K2039/505A61K2039/54

Quick answer

US patent 10370449 (Methods for treating skin infection by administering an IL-4R antagonist) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/505, A61K2039/54, A61K39/3955, A61K45/06